[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"iron-deficiency-anemia-of-pregnancy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:iron-deficiency-anemia-of-pregnancy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,54,89,114],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100548807","adiposity-and-iron-requirements-in-pregnancy-100548807",false,"NCT06425796","Adiposity and Iron Requirements in Pregnancy","Impact of Maternal Adiposity on Maternal Iron Status and Requirements: a Randomised Intervention Study","ADIPREG","Inclusion Criteria:- Pregnant women\n\n* Age ≥ 18 years\n* BMI ≥18.5 kg\u002Fm2\n* Without current pregnancy complications (for example, severe bleeding, Diabetes Mellitus, hyperemesis gravidarum, ectopic and molar pregnancies)\n* At least 12 Gestational Week\n* Singleton pregnancy confirmed with the first ultrasound scan\n* Participants who are currently taking multivitamins will be included. They will be asked to discontinue any current supplementation.\n\nExclusion Criteria:\n\n* Hb \\\u003C110 g\u002FL\n* SF \\\u003C30 μg\u002FL\n* High risk of iron overload (Hb \\>150 g\u002FL, transferrin saturation \\>45% or SF\\> 150 μg\u002FL)\n* Participants with history of haematological, renal, liver, autoimmune disorders, malabsorptive syndromes\n* Participants with history of bariatric surgery\n* Participants who take steroids or anti-inflammatory treatments or drugs that affect gut absorption (proton-pump inhibitors)\n* Planned home births\n* Participants currently involved in another research study\n* Multiple pregnancy\n* Participants who do not speak English",true,"FEMALE","18 Years",{"count":21,"type":22},312,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study aims to explore how body fat influences the response to either 25 or 50 mg of daily iron supplements during pregnancy. We will conduct a double-blind randomized controlled intervention study involving 312 pregnant women recruited from antenatal clinics in the Northern Trust Area. Participants will be randomly assigned to receive either 25 or 50 mg of iron per day from 12 weeks of pregnancy until delivery, using the Active Iron supplement brand. Blood samples will be collected at 12, 28 and 36 weeks gestation and umbilical cord blood will be collected at delivery. Anthropometric measurements will be taken at each visit, and participants will complete questionnaires on various aspects of health and lifestyle, mental health, gastrointestinal symptoms, and compliance.",[28],"Iron Deficiency Anemia of Pregnancy",[30,31,32,33,34,35,36,37,38,39,40],"Iron status","Iron Supplements","Pregnancy","Anaemia","Maternal obesity","Maternal Overweight","Body composition","Ferritin","Inflammation","Mental Health","Neonatal anaemia","RECRUITING","2026-06-30",{"date":44,"type":45},"2026-07-01","ACTUAL",{"date":47,"type":45},"2024-05-20",{"date":49,"type":22},"2027-03-19",{"name":51,"class":52},"University of Ulster","OTHER",3,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":62,"targetDuration":4,"studyType":64,"phases":4,"briefSummary":65,"conditions":66,"keywords":74,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":88},"100599361","non-invasive-detection-of-iron-deficiency-in-obstetrics-100599361","NCT07083492","Non-invasive Detection of Iron Deficiency in Obstetrics","Point-of-care Transcutaneous Longitudinal Non-invasive Detection of Iron Deficiency in Obstetrics (PICCOLINO-Trial)","PICCOLINO","Inclusion Criteria:\n\n* any timepoint during or up to 3 months after pregnancy\n* age ≥ 18 years\n* written informed consent\n\nExclusion Criteria:\n\n* previous participation in this study\n* refusal of blood sampling\n* incapacity to give informed consent",{"count":63,"type":22},500,"OBSERVATIONAL","Validation of non-invasive measurement of zinc protoporphyrin for detection of iron deficiency in pregnancy.\n\nIn addition, the impact of iron deficiency on the incidence of postpartum depression, restless legs syndrome, obstetric complications and quality of life will be examined.",[28,67,68,69,70,71,72,73],"Iron-deficiency","Restless Leg Syndrome in Pregnancy","Restless Leg Syndrome Due to Iron Deficiency Anaemia","Postpartum Hemorrhage","Postpartum Depression","Pregnancy Anemia","Iron Deficiency (Without Anemia)",[75,76,77,78],"Zinc protoporphyrin","Non-invasive detection","Obstetric anesthesia","Patient blood management","2025-07-23",{"date":81,"type":45},"2025-07-24",{"date":83,"type":45},"2022-11-15",{"date":85,"type":22},"2026-12-31",{"name":87,"class":52},"Wuerzburg University Hospital",1,{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":4,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":96,"enrollmentInfo":97,"targetDuration":4,"studyType":23,"phases":99,"briefSummary":100,"conditions":101,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":88},"100363125","hepcidin-and-glucose-metabolism-100363125","NCT04008147","Hepcidin and Glucose Metabolism","The Effect of Oral Iron Supplements on Hepcidin, Insulin and Glucose Metabolism in Pregnancy","Inclusion Criteria:\n\n* week of pregnancy 24-28\n* pre-pregnancy BMI \\\u003C27.5kg\u002Fm2\n* singleton pregnancy\n* Hb \\> 8.0 g\u002Fdl\n\nWilling to either:\n\n* not take any iron supplements for 14 days (however, participants will receive a similar amount of total iron during the 4 study days that they would normally receive over 14 days) OR\n* to take the multivitamin \"Burgerstein Schwangerschaft and Stillzeit\" supplements over the 14 days (contains 30 mg iron)\n\nExclusion Criteria:\n\n* iron infusion within the past 6 months\n* severely anemic Hb\\\u003C8.0g\u002Fdl\n* acute or chronic disease\n* long-term medication\n* medical problems known to affect iron homeostasis\n* smoking","45 Years",{"count":98,"type":22},30,[25],"Gestational diabetes mellitus (GDM), defined as hyperglycemia with blood glucose values above normal but below those diagnostic of DM, and iron deficiency (ID) with or without anemia (IDA) are common during pregnancy. Both disease patterns are associated with an increased risk of complications during pregnancy and at delivery and may have a variety of negative effects on different aspects of child development. Thus, GDM and ID\u002FIDA during pregnancy should be prevented.\n\nWhether iron supplementation with high oral doses acutely increases hepcidin during pregnancy, and whether this acute iron-induced increase in hepcidin decreases insulin sensitivity, is uncertain.",[28,102,103,104],"Iron Metabolism Disorders","Glucose Intolerance","Gestational Diabetes","2025-05-19",{"date":107,"type":45},"2025-05-22",{"date":109,"type":45},"2019-07-03",{"date":111,"type":22},"2025-12-31",{"name":113,"class":52},"Swiss Federal Institute of Technology",{"id":115,"slug":116,"hasResults":11,"nctId":117,"briefTitle":118,"officialTitle":119,"acronym":4,"eligibilityCriteria":120,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":121,"phases":4,"briefSummary":122,"conditions":123,"keywords":4,"overallStatus":124,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":128,"locationsCount":4},"100450913","chelated-oral-iron-versus-intravenous-iron-sucrose-for-treatment-of-iron-deficiency-anemia-late-in-pregnancy-100450913","NCT05151679","Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy","Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy ( Randomized Controlled Trial )","Inclusion Criteria:\n\n1. Women aged 18 years or more with established iron deficiency anemia ( Hb: 8-10 )\n2. Pregnancy 26-34 weeks\n\nExclusion Criteria:\n\n1. Anemia due to other causes than iron deficiency anemia.\n2. Recent blood transfusion (in the last 3 months ).\n3. Allergy to iron.\n4. Multiple pregnancy.","EXPANDED_ACCESS","compare the efficacy and safety of intravenous iron sucrose versus chelated oral iron in the treatment of iron deficiency anemia late in pregnancy.",[28],"AVAILABLE","2021-11-28",{"date":127,"type":45},"2021-12-09",{"name":129,"class":52},"Assiut University"]